(Pixabay)
(ABC 27) – A congressional watchdog agency has determined that the oversight carried out by the Department of Health and Human Services (HHS) for research involving highly transmissible viruses such as the coronavirus lacks clarity when it comes to the requirements for such studies and is recommending that the department develop new standards for assessing risk.
The Government Accountability Office (GAO) conducted a study of its own looking into federal monitoring of gain-of-function research. This inquiry was prompted by a provision included the CARES Act that tasked the agency with looking into ongoing efforts to prepare for, respond to and recover from the COVID-19 pandemic.
WND is now on Trump's Truth Social! Follow us @WNDNews
Gain-of-function research, which has come under heightened congressional scrutiny throughout the pandemic, is a process in which pathogens are altered in a way that improves their ability to cause disease. This form of research is often conducted to assess the potential dangers of infectious diseases and can be used to inform public health preparedness.
The post HHS policy for monitoring gain-of-function virus research unclear, GAO says appeared first on WND.
